Valeant Pharmaceuticals International Inc (NYSE:VRX)

17.18
Delayed Data
As of Apr 20
 -0.15 / -0.87%
Today’s Change
8.31
Today|||52-Week Range
24.43
-17.32%
Year-to-Date

Today’s Trading

Previous close17.33
Today’s open17.24
Day’s range16.98 - 17.39
Volume4,933,810
Average volume (3 months)13,617,719
Market cap$5.4B
Data as of 4:01pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-21.33%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-9.82%
P/E ratio2.5
Price/Sales0.84
Price/Book0.92

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV-1.28-1.31%
ACADACADIA Pharmaceutica...+0.24+1.22%
TAROTaro Pharmaceutical ...+0.39+0.39%
----
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)$0.69
Annual revenue (last year)$8.7B
Annual profit (last year)$2.4B
Net profit margin27.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive Vice President
Paul S. Herendeen
Corporate headquarters
Laval, Qubec

Forecasts